The Vimian Group is a global and fast-growing group of innovation-driven companies that share a passion for making a positive impact through improving animal health. Vimian Group’s Specialty Pharma segment Nextmune has acquired the veterinary allergy division, Avacta Animal Health, from AvactaGroup plc.

Avacta Animal Health provides veterinary allergy diagnostic solutions through its laboratory in Wetherby (UK) and re-sells Nextmune’s immunotherapy products to veterinary clinics across the UK. The business division also provides testing kits to veterinary laboratories in other European countries. The acquisition is a carve-out from AvactaGroup plc, a UK-based company focused on diagnostic solutions for human health.

The business had revenues of GBP 1.6 million in 2021.